Brain-injured Patients Extubation Readiness Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

The BIPER study is a stepped wedge cluster randomised clinical trial aiming to decrease extubation failure in critically-ill brain-injured patients with residual impaired consciousness using a simple clinical score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Acute cerebral lesion with a Glasgow Coma Scale <13 needing admission in ICU and mechanical ventilation with tracheal intubation for neurological cause : cerebrovascular stroke either ischemic or hemorrhagic including aneurysmal subarachnoid hemorrhage, traumatic brain injury, anoxo ischemic encephalopathy after cardiac arrest or brain tumour

Mechanical ventilation more than 48 hours

18 to 75 years old

Neurological stability with no intracranial hypertension with minimal sedation

Disqualifiers

Posterior cranial fossa lesion

Admission for status epilepticus or central nervous system infection

Spinal cord injury (tetraplegia or paraplegia)

Uncontrolled status epilepticus or uncontrolled central nervous system infection

Trial design

Design model

Parallel

Treatments tested in this trial

  • Extubation readiness clinical score

    Procedure/Surgery

    After treatment of the acute neurological condition, eligibility for a spontaneous breathing trial will be assessed once a day. In the intervention group, after a successful spontaneous breathing trial in unconscious patients, the score will be evaluated. If the score is \> 9, extubation has to be completed.

  • Usual Care

    Procedure/Surgery

    After treatment of the acute neurological condition, eligibility for a spontaneous breathing trial will be assessed once a day. In the control group, after a successful spontaneous breathing trial in unconscious patients, the extubation will be achieved according to usual care.

Treatment groups

660 Participants
are divided into 2 treatment groups
Group A: Usual careActive comparator 1 intervention
Group B: Extubation readiness clinical scoreExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Extubation failure

Extubation failure is defined as a need of reintubation or death in the 5 days (120 hours) following extubation

Time frame
From extubation to Day 5 (120 hours) after extubation

Secondary outcomes

1

Key secondary outcome measure: time to effective extubation

Time from SBT success (enrollment) to successful liberation from mechanical ventilation, defined as the time point at which a patient is alive and free of invasive ventilatory support for more than 5 days (120 hours)

Time frame
From enrollment to day 5 (120 hours) after extubation
2

Invasive mechanical ventilation duration

Period expressed in days during which patients will need invasive mechanical ventilation

Time frame
From admission to the end of ICU Stay
3

Non-invasive mechanical ventilation duration

Period expressed in days during which patients will need non-invasive mechanical ventilation

Time frame
From admission to the end of ICU Stay
4

Reintubation rate in the first 48 hours

Patients needing reintubation during the first 48h post-extubation

Time frame
From extubation to Day 2 after extubation (48 hours)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Clermont-Ferrand

Lead sponsor

ANARLF Network

Collaborator

Direction Générale de l'Offre de Soin (DGOS)

Collaborator